Hexobarbital has 2 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Clorazepate Dipotassium, Azithromycin. Patients taking Hexobarbital should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Major
- 1
- Moderate
- 1
Major (1)
- Hexobarbital + Clorazepate Dipotassium— Clorazepate dipotassium prolongs sleeping time after hexobarbital.
Moderate (1)
- Hexobarbital + Azithromycin— Macrolide products including azithromycin may increase hexobarbital concentrations. Careful monitoring is advised.